Anca Apavaloaei

5PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 22, 2025
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer.

Anca Apavaloaei, Qingchuan Zhao, Leslie Hesnard

|Oct 02, 2023
Immunotargeting of a recurrent AML-specific neoantigen.

Anca Apavaloaei, Claude Perreault

|Sep 16, 2020
The Origin and Immune Recognition of Tumor-Specific Antigens.

Anca Apavaloaei, Marie-Pierre Hardy, Pierre Thibault

|Feb 28, 2019
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.

Ida Hafstrand, Ece Canan Sayitoglu, Anca Apavaloaei

|Dec 21, 2018
PSMB11 Orchestrates the Development of CD4 and CD8 Thymocytes via Regulation of Gene Expression in Cortical Thymic Epithelial Cells.

Anca Apavaloaei, Sylvie Brochu, Mengqi Dong

Pageof 1